Neuralia TMS Extends Depression Treatment Access for Australian Patients
Australia, 23rd Jul 2026 – Neuralia TMS, a prominent provider of Transcranial Magnetic Stimulation (TMS) therapy based in Como, Western Australia, has announced an extension of treatment access for patients across Australia seeking non-invasive, drug-free options for managing depression. The extension centres on the clinic’s combined delivery model, which pairs in-clinic TMS sessions with at-home transcranial Direct Current Stimulation (tDCS) therapy and pharmacogenetic testing, reducing the need for patients outside the Perth metropolitan area to travel for ongoing care.
The development is relevant to patients in regional and interstate locations who have previously faced logistical barriers to accessing structured mental health treatment, and reflects broader industry attention on maki...
